Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001918845-26-000002

Options or other derivatives

  • Chief Medical Officer acquired 105,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Doyle Mittie Chief Medical Officer 2026-02-26 Grant or award · Stock Option (Right to Buy) +105,000 105,000 D: show line 1 in the form
Loading xslF345X05/form4-03022026_090303.xml…